Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells

Oncogene

Volumn 23, Issue 12, 2004, Pages 2188-2196

  Castellone, Maria Domenica ^a   Celetti, Angela ^a   Guarino, Valentina ^a   Cirafici, Anna Maria ^a   Basolo, Fulvio ^b   Giannini, Riccardo ^b   Medico, Enzo ^c   Kruhoffer, Mogens ^d   Orntoft, Torben F ^d   Curcio, Francesco ^e   Fusco, Alfredo ^a   Melillo, Rosa Marina ^a   Santoro, Massimo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Dipartimento di Biologia   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e UNIVERSITY OF UDINE   (Italy)

Author keywords

Carcinoma; Kinase; Motility; Ras; Thyroid; Tyrosine

Indexed keywords

COLLAGEN GEL; GLYCOPROTEIN; HERMES ANTIGEN; MATRIGEL; OSTEOPONTIN; PHOSPHOTRANSFERASE; PROTEIN RET; RECEPTOR; TYROSINE; COLLAGEN; COLLAGEN TYPE 1; DNA; LAMININ; ONCOPROTEIN; PROTEIN TYROSINE KINASE; PROTEOGLYCAN; RECOMBINANT PROTEIN; SIALOGLYCOPROTEIN; SPP1 PROTEIN, HUMAN;

ARTICLE; AUTOCRINE EFFECT; AUTOPHOSPHORYLATION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MITOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; THYROID FOLLICLE CELL; UPREGULATION; BIOSYNTHESIS; CANCER INVASION; CELL DIVISION; CELL TRANSFORMATION; CHEMISTRY; DRUG COMBINATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PAPILLARY CARCINOMA; PATHOLOGY; PHOSPHORYLATION; PROTEIN TERTIARY STRUCTURE; THYROID TUMOR; TUMOR CELL LINE;

ANTIGENS, CD44; CARCINOMA, PAPILLARY; CELL DIVISION; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; COLLAGEN; COLLAGEN TYPE I; DNA; DRUG COMBINATIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LAMININ; NEOPLASM INVASIVENESS; OSTEOPONTIN; PHENOTYPE; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; PROTEOGLYCANS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECOMBINANT PROTEINS; SIALOGLYCOPROTEINS; SIGNAL TRANSDUCTION; THYROID NEOPLASMS; TYROSINE;

EID: 11144355973     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207322     Document Type: Article

References (39)

1. Andreozzi F, Melillo RM, Carlomagno F, Oriente F, Miele C, Fiory F, Santopietro S, Castellone MD, Beguinot F, Santoro M and Formisano P. (2003). Oncogene, 22, 2942-2949.
2. Asai N, Murakami H, Iwashita T and Takahashi M. (1996). J. Biol. Chem., 271, 17644-17649.
3. Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, Rittling SR, Denhardt DT, Glimcher MJ and Cantor H. (2000). Science, 287, 860-864.
4. Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A, Inohara H, Marandino F, Orlandi F, Nardi F, Vecchione A, Tecce R and Larsson O. (2001). Lancet, 357, 1644-1650.
5. Basolo F, Giannini R, Toniolo A, Casalone R, Nikiforova M, Pacini F, Elisei R, Miccoli P, Berti P, Faviana P, Fiore L, Monaco C, Pierantoni GM, Fedele M, Nikiforov YE, Santoro M and Fusco A. (2002). Int. J. Cancer, 97, 608-614.
6. Borrello MG, Alberti L, Arighi E, Bongarzone I, Battistini C, Bardelli A, Pasini B, Piutti C, Rizzetti MG, Mondellini P, Radice MT and Pierotti MA. (1996). Mol. Cell. Biol., 16, 2151-2163.
7. Buckwalter TL, Venkateswaran A, Lavender M, La Perle KM, Cho JY, Robinson ML and Jhiang SM. (2002). Oncogene, 21, 8166-8172.
8. Carlomagno F, Vitagliano D, Guida T, Ciardiello F, Tortora G, Vecchio G, Ryan AJ, Fontanini G, Fusco A and Santoro M. (2002). Cancer Res., 62, 7284-7290.
9. Castellone MD, Cirafici AM, De Vita G, De Falco V, Malorni L, Tallini G, Fagin JA, Fusco A, Melillo RM and Santoro M. (2003). Oncogene, 22, 246-255.
10. Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT, Sobel RA, Lock C, Karpuj M, Pedotti R, Heller R, Oksenberg JR and Steinman L. (2001). Science, 294, 1731-1735.
11. Chang PL and Prince CW. (1993). Cancer Res., 53, 2217-2220.
12. Curcio F, Ambesi-Impiombato FS, Perrella G and Coon HG. (1994). Proc. Natl. Acad. Sci. USA, 91, 9004-9008.
13. Ermak G, Gerasimov G, Troshina K, Jennings T, Robinson L, Ross JS and Figge J. (1995). Cancer Res., 55, 4594-4598.
14. Fagin JA. (2002). Endocrinology, 143, 2025-2028.
15. Fusco A, Berlingieri MT, Di Fiore PP, Portella G, Grieco M and Vecchio G. (1987). Mol. Cell. Biol., 7, 3365-3370.
16. Guo X, Zhang YP, Mitchell DA, Denhardt DT and Chambers AF. (1995). Mol. Cell. Biol., 15, 476-487.
17. Hayashi H, Ichihara M, Iwashita T, Murakami H, Shimono Y, Kawai K, Kurokawa K, Murakumo Y, Imai T, Funahashi H, Nakao A and Takahashi M. (2000). Oncogene, 19, 4469-4475.
18. Ishizaka Y, Ushijima T, Sugimura T and Nagao M. (1990). Biochem. Biophys. Res. Commun., 168, 402-408.
19. Iwashita T, Asai N, Murakami H, Matsuyama M and Takahashi M. (1996). Oncogene, 12, 481-487.
20. Kamikura DM, Khoury H, Maroun C, Naujokas MA and Park M. (2000). Mol. Cell. Biol., 20, 3482-3496.
21. Kimura T, Van Keymeulen A, Golstein J, Fusco A, Dumont JE and Roger PP. (2001). Endocr. Rev., 22, 631-656.
22. Legg JW, Lewis CA, Parsons M, Ng T and Isacke CM. (2002). Nat. Cell Biol., 4, 399-407.
23. Lin YH, Huang CJ, Chao JR, Chen ST, Lee SF, Yen JJ and Yang-Yen HF. (2000). Mol. Cell. Biol., 20, 2734-2742.
24. Lin YH and Yang-Yen HF. (2001). J. Biol. Chem., 276, 46024-46030.
25. Manie S, Santoro M, Fusco A and Billaud M. (2001). Trends Genet., 17, 580-589.
26. Medico E, Gentile A, Lo Celso C, Williams TA, Gambarotta G, Trusolino L and Comoglio PM. (2001). Cancer Res., 61, 5861-5868.
27. Medico E, Mongiovi AM, Huff J, Jelinek MA, Follenzi A, Gaudino G, Parsons JT and Comoglio PM. (1996). Mol. Biol. Cell, 7, 495-504.
28. Melillo RM, Santoro M, Ong SH, Billaud M, Fusco A, Hadari YR, Schlessinger J and Lax I. (2001). Mol. Cell. Biol., 21, 4177-4187.
29. Mercalli E, Ghizzoni S, Arighi E, Alberti L, Sangregorio R, Radice MT, Gishizky ML, Pierotti MA and Borrello MG. (2001). Oncogene, 20, 3475-3485.
30. Miyauchi A, Alvarez J, Greenfield EM, Teti A, Grano M, Colucci S, Zambonin-Zallone A, Ross FP, Teitelbaum SL and Cheresh D. (1991). J. Biol. Chem., 266, 20369-20374.
31. Ponta H, Sherman L and Herrlich PA. (2003). Nat. Rev. Mol. Cell Biol., 4, 33-45.
32. Saavedra HI, Knauf JA, Shirokawa JM, Wang J, Ouyang B, Elisei R, Stambrook PJ and Fagin JA. (2000). Oncogene, 19, 3948-3954.
33. Salvatore D, Barone MV, Salvatore G, Melillo RM, Chiappetta G, Mineo A, Fenzi G, Vecchio G, Fusco A and Santoro M. (2000). J. Clin. Endocrinol. Metab., 85, 3898-3907.
34. Santoro M, Chiappetta G, Cerrato A, Salvatore D, Zhang L, Manzo G, Picone A, Portella G, Santelli G, Vecchio G and Fusco A. (1996). Oncogene, 12, 1821-1826.
35. Weber GF. (2001). Biochim. Biophys. Acta, 1552, 61-85.
36. Weber GF, Ashkar S, Glimcher MJ and Cantor H. (1996). Science, 271, 509-512.
37. Weiss JM, Renkl AC, Maier CS, Kimmig M, Liaw L, Ahrens T, Kon S, Maeda M, Hotta H, Uede T and Simon JC. (2001). J. Exp. Med., 194, 1219-1229.
38. Yue TL, McKenna PJ, Ohlstein EH, Farach-Carson MC, Butler WT, Johanson K, McDevitt P, Feuerstein GZ and Stadel JM. (1994). Exp. Cell Res., 214, 459-464.
39. Zhang G, He B and Weber GF. (2003). Mol. Cell. Biol., 23, 6507-6519.